Christopher Porter, MD
Associate Adjoint Professor, Pediatrics-Heme/Onc and Bone Marrow Transplantation

Recognition & Awards

• Paul Calabresi Award in Clinical/Translational Oncology Research, University of Colorado Cancer Center/NCI (2008)
  
• Alpha Omega Alpha Honor Medical Society, Alpha of Georgia Chapter, Medical College of Georgia (1998)
  

Research Interests

Teaching

Publications

• Ellison MA, Thurman G, Gearheart CM, Seewald RH, Porter CC, Ambruso DR. INF-? Enhances Nox2 Activity by Upregulating phox Proteins When Applied to Differentiating PLB-985 Cells but Does Not Induce Nox2 Activity by Itself. PLoS One. 2015;10(8):e0136766. PubMed PMID: 26317224
• Maycotte P, Gearheart CM, Barnard R, Aryal S, Mulcahy Levy JM, Fosmire SP, Hansen RJ, Morgan MJ, Porter CC, Gustafson DL, Thorburn A. STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficacious. Cancer Res. 2014 Mar 3. [Epub ahead of print] PubMed PMID: 24590058
• Gardner LA, Klawitter J, Gregory MA, Zaberezhnyy V, Baturin D, Pollyea DA, Takebe N, Christians U, Gore L, DeGregori J, Porter CC. Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1( ) leukemia. Am J Hematol. 2014 Sep;89(9):896-903. PubMed PMID: 24891015
• Maycotte P, Gearheart CM, Barnard R, Aryal S, Mulcahy Levy JM, Fosmire SP, Hansen RJ, Morgan MJ, Porter CC, Gustafson DL, Thorburn A. STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficacious. Cancer Res. 2014 May 1;74(9):2579-90. PubMed PMID: 24590058
• Gore L, DeGregori J, Porter CC. Targeting developmental pathways in children with cancer: what price success? Lancet Oncol. 2013 Feb;14(2):e70-8. PubMed PMID: 23369685
• Casás-Selves M, Kim J, Zhang Z, Helfrich BA, Gao D, Porter CC, Scarborough HA, Bunn PA Jr, Chan DC, Tan AC, DeGregori J. Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition. Cancer Res. 2012 Aug 15;72(16):4154-64. PubMed PMID: 22738915
• Sullivan KD, Padilla-Just N, Henry RE, Porter CC, Kim J, Tentler JJ, Eckhardt SG, Tan AC, DeGregori J, Espinosa JM. ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53. Nat Chem Biol. 2012 Jul;8(7):646-54. PubMed PMID: 22660439
• Porter CC, Kim J, Fosmire S, Gearheart CM, van Linden A, Baturin D, Zaberezhnyy V, Patel PR, Gao D, Tan AC, DeGregori J. Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia. Leukemia. 2012 Jun;26(6):1266-76. PubMed PMID: 22289989

Professional Memberships

• American Society of Hematology, Member
• American Society of Pediatric Hematology Oncology, Member
• American Association for Cancer Research, Member
• American Academy of Pediatrics (AAP), Fellow
• Children's Oncology Group, Member
• American Society of Gene Therapy, Member
• University of Colorado Cancer Center, Member
• Colorado Multiple Institutional Review Board, Panel C (Pediatrics), Member
• University of Colorado Cancer Center Protocol Review & Monitoring Committee, Member